{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T18:40:29Z","timestamp":1713120029158},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,14]]},"DOI":"10.7759\/cureus.58249","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T18:09:15Z","timestamp":1713118155000},"source":"Crossref","is-referenced-by-count":0,"title":["Dry Eye Disease Symptoms Among Glaucoma Patients at a Portuguese Hospital"],"prefix":"10.7759","author":[{"given":"Catarina","family":"Pestana Aguiar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Chibante-Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeniffer","family":"Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2022.07.007","article-title":"Topical glaucoma medications: clinical implications for the ocular surface","volume":"26","author":"Fineide F","year":"2022","unstructured":"Fineide F, Lagali N, Adil MY, Arita R, Kolko M, Vehof J, Utheim TP. Topical glaucoma medications: clinical implications for the ocular surface. Ocul Surf. 2022, 26:19-49. 10.1016\/j.jtos.2022.07.007","journal-title":"Ocul Surf"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000544","article-title":"Ocular surface disease and glaucoma medications: a clinical approach","volume":"45","author":"Zhang X","year":"2019","unstructured":"Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 2019, 45:11-8. 10.1097\/ICL.0000000000000544","journal-title":"Eye Contact Lens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S420932","article-title":"Glaucoma and dry eye disease: opportunity to assess and treat","volume":"17","author":"Nijm LM","year":"2023","unstructured":"Nijm LM, Schweitzer J, Gould Blackmore J. Glaucoma and dry eye disease: opportunity to assess and treat. Clin Ophthalmol. 2023, 17:3063-76. 10.2147\/OPTH.S420932","journal-title":"Clin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/APO.0000000000000327","article-title":"Understanding the dual dilemma of dry eye and glaucoma: an international review","volume":"9","author":"Nijm LM","year":"2020","unstructured":"Nijm LM, De Benito-Llopis L, Rossi GC, Vajaranant TS, Coroneo MT. Understanding the dual dilemma of dry eye and glaucoma: an international review. Asia Pac J Ophthalmol (Phila). 2020, 9:481-90. 10.1097\/APO.0000000000000327","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.7674","article-title":"Dry eye disease among patients with glaucoma under topical antiglaucoma agents in a tertiary care centre: a descriptive cross-sectional study","volume":"60","author":"Palikhey A","year":"2022","unstructured":"Palikhey A, Koiree S, Kumar Mehta R, Kumar Shrivastava A. Dry eye disease among patients with glaucoma under topical antiglaucoma agents in a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2022, 60:800-4. 10.31729\/jnma.7674","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8071076","article-title":"Dry eye symptoms and ocular pain in veterans with glaucoma","volume":"8","author":"Tirpack AR","year":"2019","unstructured":"Tirpack AR, Vanner E, Parrish JM, Galor A, Hua HU, Wellik SR. Dry eye symptoms and ocular pain in veterans with glaucoma. J Clin Med. 2019, 8:1076. 10.3390\/jcm8071076","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-01917-3","article-title":"Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia","volume":"21","author":"Sahlu M","year":"2021","unstructured":"Sahlu M, Giorgis AT. Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia. BMC Ophthalmol. 2021, 21:155. 10.1186\/s12886-021-01917-3","journal-title":"BMC Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.20344\/amp.18557","article-title":"Adaptation of the Standardized Patient Evaluation of Eye Dryness Questionnaire to European Portuguese (SPEED-Vp) in a non-clinical sample","volume":"36","author":"Sanches AL","year":"2023","unstructured":"Sanches AL, Leite SG, Nunes A, Caixinha M, Monteiro P, Nunes A. Adaptation of the Standardized Patient Evaluation of Eye Dryness Questionnaire to European Portuguese (SPEED-Vp) in a non-clinical sample. Acta Med Port. 2023, 36:714-22. 10.20344\/amp.18557","journal-title":"Acta Med Port"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.9.32","article-title":"Topical glaucoma therapy is associated with alterations of the ocular surface microbiome","volume":"63","author":"Chang CJ","year":"2022","unstructured":"Chang CJ, Somohano K, Zemsky C, et al.. Topical glaucoma therapy is associated with alterations of the ocular surface microbiome. Invest Ophthalmol Vis Sci. 2022, 63:32. 10.1167\/iovs.63.9.32","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1240537","article-title":"Extracellular MMP-9-based assessment of ocular surface inflammation in patients with primary open-angle glaucoma","volume":"2019","author":"Zaleska-\u017bmijewska A","year":"2019","unstructured":"Zaleska-\u017bmijewska A, Strzemecka E, Wawrzyniak ZM, Szaflik JP. Extracellular MMP-9-based assessment of ocular surface inflammation in patients with primary open-angle glaucoma. J Ophthalmol. 2019, 2019:1240537. 10.1155\/2019\/1240537","journal-title":"J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9907","article-title":"Surface chemistry study of the interactions of pharmaceutical ingredients with human meibum films","volume":"53","author":"Georgiev GA","year":"2012","unstructured":"Georgiev GA, Yokoi N, Ivanova S, Krastev R, Lalchev Z. Surface chemistry study of the interactions of pharmaceutical ingredients with human meibum films. Invest Ophthalmol Vis Sci. 2012, 53:4605-15. 10.1167\/iovs.12-9907","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0021-8","article-title":"Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface","volume":"30","author":"Lee S","year":"2013","unstructured":"Lee S, Kim MK, Choi HJ, Wee WR, Kim DM. Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface. Adv Ther. 2013, 30:420-9. 10.1007\/s12325-013-0021-8","journal-title":"Adv Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000542","article-title":"Ocular surface disease in glaucoma: effect of polypharmacy and preservatives","volume":"92","author":"Ramli N","year":"2015","unstructured":"Ramli N, Supramaniam G, Samsudin A, Juana A, Zahari M, Choo MM. Ocular surface disease in glaucoma: effect of polypharmacy and preservatives. Optom Vis Sci. 2015, 92:e222-6. 10.1097\/OPX.0000000000000542","journal-title":"Optom Vis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000899","article-title":"Meibomian gland features and conjunctival goblet cell density in glaucomatous patients controlled with prostaglandin\/timolol fixed combinations: a case control, cross-sectional study","volume":"27","author":"Agnifili L","year":"2018","unstructured":"Agnifili L, Mastropasqua R, Fasanella V, Brescia L, Scatena B, Oddone F, Mastropasqua L. Meibomian gland features and conjunctival goblet cell density in glaucomatous patients controlled with prostaglandin\/timolol fixed combinations: a case control, cross-sectional study. J Glaucoma. 2018, 27:364-70. 10.1097\/IJG.0000000000000899","journal-title":"J Glaucoma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2022.07.012","article-title":"Benzalkonium chloride, a common ophthalmic preservative, compromises rat corneal cold sensitive nerve activity","volume":"26","author":"Ivakhnitskaia E","year":"2022","unstructured":"Ivakhnitskaia E, Souboch V, Dallacasagrande V, et al.. Benzalkonium chloride, a common ophthalmic preservative, compromises rat corneal cold sensitive nerve activity. Ocul Surf. 2022, 26:88-96. 10.1016\/j.jtos.2022.07.012","journal-title":"Ocul Surf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240809-dry-eye-disease-symptoms-among-glaucoma-patients-at-a-portuguese-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T18:09:20Z","timestamp":1713118160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240809-dry-eye-disease-symptoms-among-glaucoma-patients-at-a-portuguese-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.58249","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,14]]}}}